Cite

    Zhang, X. et al. (2021). Discovery of a novel series of guanidinebenzoates as gut-restricted enteropeptidase and trypsin dual inhibitors for the treatment of metabolic syndrome. Bioorganic & medicinal chemistry letters. p. . [Online].